nodes	percent_of_prediction	percent_of_DWPC	metapath
Caffeine—CYP1B1—Mitoxantrone—sarcoma	0.101	0.178	CbGbCtD
Caffeine—CYP1A1—Dacarbazine—sarcoma	0.0571	0.101	CbGbCtD
Caffeine—CYP2E1—Dacarbazine—sarcoma	0.0441	0.0779	CbGbCtD
Caffeine—CYP1B1—Doxorubicin—sarcoma	0.0434	0.0767	CbGbCtD
Caffeine—CYP2E1—Mitoxantrone—sarcoma	0.0342	0.0605	CbGbCtD
Caffeine—CYP1A2—Dacarbazine—sarcoma	0.0255	0.0451	CbGbCtD
Caffeine—CYP3A7—Vincristine—sarcoma	0.0244	0.0431	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.0244	0.0431	CbGbCtD
Caffeine—CYP3A4—Thiotepa—sarcoma	0.0241	0.0426	CbGbCtD
Caffeine—CYP2E1—Etoposide—sarcoma	0.0216	0.0381	CbGbCtD
Caffeine—ABCB1—Dactinomycin—sarcoma	0.0193	0.0342	CbGbCtD
Caffeine—CYP3A5—Vincristine—sarcoma	0.0183	0.0323	CbGbCtD
Caffeine—ABCB1—Mitoxantrone—sarcoma	0.0173	0.0306	CbGbCtD
Caffeine—CYP3A5—Etoposide—sarcoma	0.0168	0.0296	CbGbCtD
Caffeine—CYP2C8—Etoposide—sarcoma	0.0161	0.0285	CbGbCtD
Caffeine—CYP1A2—Etoposide—sarcoma	0.0125	0.0221	CbGbCtD
Caffeine—ABCB1—Vincristine—sarcoma	0.0119	0.021	CbGbCtD
Caffeine—ABCB1—Etoposide—sarcoma	0.0109	0.0193	CbGbCtD
Caffeine—CYP3A4—Mitoxantrone—sarcoma	0.0104	0.0183	CbGbCtD
Caffeine—ABCB1—Doxorubicin—sarcoma	0.00745	0.0132	CbGbCtD
Caffeine—RYR1—larynx—sarcoma	0.00715	0.0546	CbGeAlD
Caffeine—CYP3A4—Vincristine—sarcoma	0.00714	0.0126	CbGbCtD
Caffeine—CYP2D6—Doxorubicin—sarcoma	0.00701	0.0124	CbGbCtD
Caffeine—CYP3A4—Etoposide—sarcoma	0.00654	0.0116	CbGbCtD
Caffeine—CYP3A4—Doxorubicin—sarcoma	0.00446	0.00788	CbGbCtD
Caffeine—PRKDC—Vinblastine—Vincristine—sarcoma	0.00366	1	CbGdCrCtD
Caffeine—Necrotising colitis—Epirubicin—sarcoma	0.00336	0.0655	CcSEcCtD
Caffeine—PIK3CD—endothelium—sarcoma	0.00333	0.0254	CbGeAlD
Caffeine—Necrotising colitis—Doxorubicin—sarcoma	0.00311	0.0606	CcSEcCtD
Caffeine—ATM—mammary gland—sarcoma	0.00303	0.0231	CbGeAlD
Caffeine—PIK3CB—endothelium—sarcoma	0.0029	0.0222	CbGeAlD
Caffeine—PIK3CA—endothelium—sarcoma	0.00287	0.0219	CbGeAlD
Caffeine—PRKDC—mammary gland—sarcoma	0.00286	0.0218	CbGeAlD
Caffeine—PIK3CD—mammary gland—sarcoma	0.00268	0.0205	CbGeAlD
Caffeine—PIK3CA—mammary gland—sarcoma	0.00232	0.0177	CbGeAlD
Caffeine—ATM—embryo—sarcoma	0.00207	0.0158	CbGeAlD
Caffeine—PRKDC—myometrium—sarcoma	0.00203	0.0155	CbGeAlD
Caffeine—ATM—hematopoietic system—sarcoma	0.00184	0.0141	CbGeAlD
Caffeine—PRKDC—seminal vesicle—sarcoma	0.00183	0.014	CbGeAlD
Caffeine—PIK3CD—embryo—sarcoma	0.00183	0.014	CbGeAlD
Caffeine—ATM—connective tissue—sarcoma	0.00178	0.0135	CbGeAlD
Caffeine—Cerebral haemorrhage—Thiotepa—sarcoma	0.00174	0.0339	CcSEcCtD
Caffeine—PIK3CB—myometrium—sarcoma	0.00166	0.0127	CbGeAlD
Caffeine—RYR1—myometrium—sarcoma	0.00164	0.0125	CbGeAlD
Caffeine—PIK3CA—myometrium—sarcoma	0.00164	0.0125	CbGeAlD
Caffeine—PIK3CD—hematopoietic system—sarcoma	0.00164	0.0125	CbGeAlD
Caffeine—ATM—skin of body—sarcoma	0.0016	0.0122	CbGeAlD
Caffeine—PIK3CB—embryo—sarcoma	0.0016	0.0122	CbGeAlD
Caffeine—PIK3CA—embryo—sarcoma	0.00158	0.0121	CbGeAlD
Caffeine—PIK3CD—connective tissue—sarcoma	0.00157	0.012	CbGeAlD
Caffeine—Cerebral haemorrhage—Vincristine—sarcoma	0.00154	0.0301	CcSEcCtD
Caffeine—PRKDC—smooth muscle tissue—sarcoma	0.00154	0.0117	CbGeAlD
Caffeine—PIK3CB—seminal vesicle—sarcoma	0.0015	0.0114	CbGeAlD
Caffeine—PIK3CA—seminal vesicle—sarcoma	0.00148	0.0113	CbGeAlD
Caffeine—PIK3CD—smooth muscle tissue—sarcoma	0.00144	0.011	CbGeAlD
Caffeine—PIK3CB—hematopoietic system—sarcoma	0.00143	0.0109	CbGeAlD
Caffeine—PIK3CD—skin of body—sarcoma	0.00142	0.0108	CbGeAlD
Caffeine—PIK3CA—hematopoietic system—sarcoma	0.00141	0.0108	CbGeAlD
Caffeine—ATM—cardiac atrium—sarcoma	0.0014	0.0107	CbGeAlD
Caffeine—ATM—uterus—sarcoma	0.00139	0.0106	CbGeAlD
Caffeine—PIK3CB—connective tissue—sarcoma	0.00137	0.0105	CbGeAlD
Caffeine—PIK3CA—connective tissue—sarcoma	0.00136	0.0104	CbGeAlD
Caffeine—PRKDC—cardiac atrium—sarcoma	0.00132	0.0101	CbGeAlD
Caffeine—PRKDC—uterus—sarcoma	0.00132	0.01	CbGeAlD
Caffeine—ATM—lymphoid tissue—sarcoma	0.0013	0.0099	CbGeAlD
Caffeine—PIK3CB—smooth muscle tissue—sarcoma	0.00126	0.00958	CbGeAlD
Caffeine—RYR1—smooth muscle tissue—sarcoma	0.00124	0.00949	CbGeAlD
Caffeine—PIK3CA—smooth muscle tissue—sarcoma	0.00124	0.00949	CbGeAlD
Caffeine—PIK3CB—skin of body—sarcoma	0.00124	0.00946	CbGeAlD
Caffeine—PIK3CA—skin of body—sarcoma	0.00123	0.00936	CbGeAlD
Caffeine—Haemoglobin decreased—Mitoxantrone—sarcoma	0.00121	0.0235	CcSEcCtD
Caffeine—ATM—bone marrow—sarcoma	0.00118	0.00902	CbGeAlD
Caffeine—PRKDC—tendon—sarcoma	0.00115	0.0088	CbGeAlD
Caffeine—PIK3CD—lymphoid tissue—sarcoma	0.00115	0.00878	CbGeAlD
Caffeine—PRKDC—bone marrow—sarcoma	0.00112	0.00853	CbGeAlD
Caffeine—PIK3CB—cardiac atrium—sarcoma	0.00108	0.00826	CbGeAlD
Caffeine—PIK3CB—uterus—sarcoma	0.00108	0.00822	CbGeAlD
Caffeine—PIK3CA—cardiac atrium—sarcoma	0.00107	0.00818	CbGeAlD
Caffeine—RYR1—uterus—sarcoma	0.00107	0.00813	CbGeAlD
Caffeine—PIK3CA—uterus—sarcoma	0.00107	0.00813	CbGeAlD
Caffeine—PIK3CD—bone marrow—sarcoma	0.00105	0.008	CbGeAlD
Caffeine—ATM—testis—sarcoma	0.00101	0.00771	CbGeAlD
Caffeine—PIK3CB—lymphoid tissue—sarcoma	0.001	0.00766	CbGeAlD
Caffeine—PIK3CA—lymphoid tissue—sarcoma	0.000994	0.00758	CbGeAlD
Caffeine—PRKDC—testis—sarcoma	0.000955	0.00729	CbGeAlD
Caffeine—ATM—liver—sarcoma	0.000955	0.00729	CbGeAlD
Caffeine—PIK3CB—tendon—sarcoma	0.000944	0.0072	CbGeAlD
Caffeine—RYR1—tendon—sarcoma	0.000934	0.00713	CbGeAlD
Caffeine—PIK3CA—tendon—sarcoma	0.000934	0.00713	CbGeAlD
Caffeine—ADORA2B—smooth muscle tissue—sarcoma	0.000915	0.00698	CbGeAlD
Caffeine—PIK3CB—bone marrow—sarcoma	0.000914	0.00698	CbGeAlD
Caffeine—PIK3CA—bone marrow—sarcoma	0.000905	0.0069	CbGeAlD
Caffeine—PRKDC—liver—sarcoma	0.000903	0.00689	CbGeAlD
Caffeine—PIK3CD—testis—sarcoma	0.000896	0.00684	CbGeAlD
Caffeine—ADORA2A—hematopoietic system—sarcoma	0.000864	0.00659	CbGeAlD
Caffeine—Pulmonary oedema—Thiotepa—sarcoma	0.000856	0.0167	CcSEcCtD
Caffeine—PIK3CD—liver—sarcoma	0.000847	0.00646	CbGeAlD
Caffeine—Sepsis—Thiotepa—sarcoma	0.000834	0.0163	CcSEcCtD
Caffeine—Sepsis—Dactinomycin—sarcoma	0.000828	0.0162	CcSEcCtD
Caffeine—PIK3CB—testis—sarcoma	0.000782	0.00596	CbGeAlD
Caffeine—Deafness—Thiotepa—sarcoma	0.00078	0.0152	CcSEcCtD
Caffeine—CYP1B1—mammary gland—sarcoma	0.000776	0.00592	CbGeAlD
Caffeine—PIK3CA—testis—sarcoma	0.000773	0.0059	CbGeAlD
Caffeine—RYR1—testis—sarcoma	0.000773	0.0059	CbGeAlD
Caffeine—Urine output increased—Vincristine—sarcoma	0.000771	0.015	CcSEcCtD
Caffeine—ADORA1—hematopoietic system—sarcoma	0.000746	0.00569	CbGeAlD
Caffeine—PIK3CB—liver—sarcoma	0.000739	0.00564	CbGeAlD
Caffeine—ATM—lymph node—sarcoma	0.000732	0.00559	CbGeAlD
Caffeine—RYR1—liver—sarcoma	0.000731	0.00558	CbGeAlD
Caffeine—PIK3CA—liver—sarcoma	0.000731	0.00558	CbGeAlD
Caffeine—Sepsis—Mitoxantrone—sarcoma	0.000721	0.0141	CcSEcCtD
Caffeine—PRKDC—lymph node—sarcoma	0.000692	0.00528	CbGeAlD
Caffeine—Deafness—Vincristine—sarcoma	0.000692	0.0135	CcSEcCtD
Caffeine—Blood creatinine increased—Thiotepa—sarcoma	0.000654	0.0128	CcSEcCtD
Caffeine—PIK3CD—lymph node—sarcoma	0.000649	0.00496	CbGeAlD
Caffeine—ADORA2A—lymphoid tissue—sarcoma	0.000608	0.00464	CbGeAlD
Caffeine—Gastrointestinal haemorrhage—Mitoxantrone—sarcoma	0.000603	0.0118	CcSEcCtD
Caffeine—Sepsis—Etoposide—sarcoma	0.000599	0.0117	CcSEcCtD
Caffeine—CYP2C8—mammary gland—sarcoma	0.000594	0.00454	CbGeAlD
Caffeine—ADORA2B—testis—sarcoma	0.000569	0.00434	CbGeAlD
Caffeine—PIK3CB—lymph node—sarcoma	0.000566	0.00432	CbGeAlD
Caffeine—ADORA1—cardiac atrium—sarcoma	0.000566	0.00432	CbGeAlD
Caffeine—Blood creatinine increased—Mitoxantrone—sarcoma	0.000565	0.011	CcSEcCtD
Caffeine—PIK3CA—lymph node—sarcoma	0.000561	0.00428	CbGeAlD
Caffeine—Hypercalcaemia—Epirubicin—sarcoma	0.000557	0.0109	CcSEcCtD
Caffeine—PDE4B—hematopoietic system—sarcoma	0.000552	0.00421	CbGeAlD
Caffeine—Hyperglycaemia—Thiotepa—sarcoma	0.000544	0.0106	CcSEcCtD
Caffeine—Infestation—Thiotepa—sarcoma	0.000538	0.0105	CcSEcCtD
Caffeine—Infestation NOS—Thiotepa—sarcoma	0.000538	0.0105	CcSEcCtD
Caffeine—Renal failure—Thiotepa—sarcoma	0.000529	0.0103	CcSEcCtD
Caffeine—CYP2C9—mammary gland—sarcoma	0.000528	0.00403	CbGeAlD
Caffeine—Hypercalcaemia—Doxorubicin—sarcoma	0.000516	0.0101	CcSEcCtD
Caffeine—ADORA1—tendon—sarcoma	0.000494	0.00377	CbGeAlD
Caffeine—Haemoglobin—Thiotepa—sarcoma	0.000485	0.00947	CcSEcCtD
Caffeine—Haemorrhage—Thiotepa—sarcoma	0.000483	0.00942	CcSEcCtD
Caffeine—CYP3A7—liver—sarcoma	0.000481	0.00367	CbGeAlD
Caffeine—ADORA2A—testis—sarcoma	0.000473	0.00361	CbGeAlD
Caffeine—CYP1B1—hematopoietic system—sarcoma	0.000473	0.00361	CbGeAlD
Caffeine—Hyperglycaemia—Mitoxantrone—sarcoma	0.00047	0.00917	CcSEcCtD
Caffeine—Renal failure—Mitoxantrone—sarcoma	0.000457	0.00891	CcSEcCtD
Caffeine—CYP1B1—connective tissue—sarcoma	0.000455	0.00347	CbGeAlD
Caffeine—Cardiac disorder—Thiotepa—sarcoma	0.000448	0.00874	CcSEcCtD
Caffeine—ADORA2A—liver—sarcoma	0.000448	0.00342	CbGeAlD
Caffeine—Immune system disorder—Thiotepa—sarcoma	0.000436	0.00851	CcSEcCtD
Caffeine—Malnutrition—Thiotepa—sarcoma	0.00042	0.0082	CcSEcCtD
Caffeine—Haemoglobin—Mitoxantrone—sarcoma	0.000419	0.00818	CcSEcCtD
Caffeine—PDE4B—cardiac atrium—sarcoma	0.000419	0.0032	CbGeAlD
Caffeine—Haemorrhage—Mitoxantrone—sarcoma	0.000417	0.00814	CcSEcCtD
Caffeine—CYP1B1—smooth muscle tissue—sarcoma	0.000417	0.00318	CbGeAlD
Caffeine—CYP1B1—skin of body—sarcoma	0.000411	0.00314	CbGeAlD
Caffeine—CYP3A7-CYP3A51P—liver—sarcoma	0.000409	0.00312	CbGeAlD
Caffeine—ADORA1—testis—sarcoma	0.000409	0.00312	CbGeAlD
Caffeine—Nervousness—Thiotepa—sarcoma	0.000408	0.00797	CcSEcCtD
Caffeine—Creatinine increased—Epirubicin—sarcoma	0.000407	0.00794	CcSEcCtD
Caffeine—Cardiac disorder—Vincristine—sarcoma	0.000397	0.00775	CcSEcCtD
Caffeine—PDE4B—lymphoid tissue—sarcoma	0.000389	0.00296	CbGeAlD
Caffeine—Infestation—Etoposide—sarcoma	0.000386	0.00754	CcSEcCtD
Caffeine—Infestation NOS—Etoposide—sarcoma	0.000386	0.00754	CcSEcCtD
Caffeine—Agitation—Thiotepa—sarcoma	0.000386	0.00754	CcSEcCtD
Caffeine—Renal failure—Etoposide—sarcoma	0.00038	0.00741	CcSEcCtD
Caffeine—Creatinine increased—Doxorubicin—sarcoma	0.000376	0.00734	CcSEcCtD
Caffeine—PDE4B—tendon—sarcoma	0.000365	0.00279	CbGeAlD
Caffeine—Convulsion—Thiotepa—sarcoma	0.000364	0.00711	CcSEcCtD
Caffeine—Hypertension—Thiotepa—sarcoma	0.000363	0.00708	CcSEcCtD
Caffeine—CYP2C8—hematopoietic system—sarcoma	0.000362	0.00276	CbGeAlD
Caffeine—CYP1B1—uterus—sarcoma	0.000357	0.00273	CbGeAlD
Caffeine—PDE4B—bone marrow—sarcoma	0.000354	0.0027	CbGeAlD
Caffeine—Pulmonary oedema—Epirubicin—sarcoma	0.000345	0.00672	CcSEcCtD
Caffeine—Agitation—Vincristine—sarcoma	0.000343	0.00668	CcSEcCtD
Caffeine—Infection—Thiotepa—sarcoma	0.000341	0.00665	CcSEcCtD
Caffeine—CYP1A2—hematopoietic system—sarcoma	0.000339	0.00259	CbGeAlD
Caffeine—Infection—Dactinomycin—sarcoma	0.000338	0.0066	CcSEcCtD
Caffeine—Nervous system disorder—Thiotepa—sarcoma	0.000336	0.00656	CcSEcCtD
Caffeine—Sepsis—Epirubicin—sarcoma	0.000336	0.00656	CcSEcCtD
Caffeine—Tachycardia—Thiotepa—sarcoma	0.000335	0.00653	CcSEcCtD
Caffeine—CYP1A1—hematopoietic system—sarcoma	0.000334	0.00255	CbGeAlD
Caffeine—Skin disorder—Thiotepa—sarcoma	0.000333	0.0065	CcSEcCtD
Caffeine—CYP1B1—lymphoid tissue—sarcoma	0.000333	0.00254	CbGeAlD
Caffeine—CYP3A5—hematopoietic system—sarcoma	0.000327	0.00249	CbGeAlD
Caffeine—Convulsion—Vincristine—sarcoma	0.000323	0.0063	CcSEcCtD
Caffeine—Cardiac disorder—Etoposide—sarcoma	0.000322	0.00628	CcSEcCtD
Caffeine—Hypertension—Vincristine—sarcoma	0.000322	0.00628	CcSEcCtD
Caffeine—CYP2C9—hematopoietic system—sarcoma	0.000322	0.00245	CbGeAlD
Caffeine—CYP2E1—seminal vesicle—sarcoma	0.000321	0.00245	CbGeAlD
Caffeine—Pulmonary oedema—Doxorubicin—sarcoma	0.000319	0.00622	CcSEcCtD
Caffeine—Convulsion—Mitoxantrone—sarcoma	0.000314	0.00614	CcSEcCtD
Caffeine—Hypertension—Mitoxantrone—sarcoma	0.000313	0.00612	CcSEcCtD
Caffeine—Immune system disorder—Etoposide—sarcoma	0.000313	0.00611	CcSEcCtD
Caffeine—CYP1B1—tendon—sarcoma	0.000313	0.00239	CbGeAlD
Caffeine—Sepsis—Doxorubicin—sarcoma	0.000311	0.00607	CcSEcCtD
Caffeine—CYP2E1—hematopoietic system—sarcoma	0.000305	0.00233	CbGeAlD
Caffeine—PDE4B—testis—sarcoma	0.000302	0.00231	CbGeAlD
Caffeine—Infection—Vincristine—sarcoma	0.000302	0.0059	CcSEcCtD
Caffeine—Nervous system disorder—Vincristine—sarcoma	0.000298	0.00582	CcSEcCtD
Caffeine—ADORA1—lymph node—sarcoma	0.000296	0.00226	CbGeAlD
Caffeine—Gastrointestinal disorder—Thiotepa—sarcoma	0.000296	0.00578	CcSEcCtD
Caffeine—Infection—Mitoxantrone—sarcoma	0.000294	0.00574	CcSEcCtD
Caffeine—CYP1A1—skin of body—sarcoma	0.000291	0.00222	CbGeAlD
Caffeine—Tachycardia—Mitoxantrone—sarcoma	0.000289	0.00564	CcSEcCtD
Caffeine—Hypoglycaemia—Epirubicin—sarcoma	0.000288	0.00562	CcSEcCtD
Caffeine—Skin disorder—Mitoxantrone—sarcoma	0.000288	0.00562	CcSEcCtD
Caffeine—PDE4B—liver—sarcoma	0.000286	0.00218	CbGeAlD
Caffeine—Gastrointestinal haemorrhage—Epirubicin—sarcoma	0.000281	0.00548	CcSEcCtD
Caffeine—Hypoglycaemia—Doxorubicin—sarcoma	0.000266	0.0052	CcSEcCtD
Caffeine—Dyspnoea—Mitoxantrone—sarcoma	0.000264	0.00515	CcSEcCtD
Caffeine—Blood creatinine increased—Epirubicin—sarcoma	0.000263	0.00514	CcSEcCtD
Caffeine—Gastrointestinal disorder—Vincristine—sarcoma	0.000263	0.00512	CcSEcCtD
Caffeine—Convulsion—Etoposide—sarcoma	0.000262	0.0051	CcSEcCtD
Caffeine—Hypertension—Etoposide—sarcoma	0.000261	0.00509	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.00026	0.00507	CcSEcCtD
Caffeine—CYP1B1—testis—sarcoma	0.000259	0.00198	CbGeAlD
Caffeine—Dry skin—Epirubicin—sarcoma	0.000258	0.00503	CcSEcCtD
Caffeine—CYP1A1—cardiac atrium—sarcoma	0.000254	0.00194	CbGeAlD
Caffeine—Hypersensitivity—Thiotepa—sarcoma	0.000253	0.00493	CcSEcCtD
Caffeine—CYP1A1—uterus—sarcoma	0.000253	0.00193	CbGeAlD
Caffeine—Hypersensitivity—Dactinomycin—sarcoma	0.000251	0.00489	CcSEcCtD
Caffeine—Gastritis—Epirubicin—sarcoma	0.000249	0.00485	CcSEcCtD
Caffeine—CYP3A4—hematopoietic system—sarcoma	0.000245	0.00187	CbGeAlD
Caffeine—CYP1B1—liver—sarcoma	0.000245	0.00187	CbGeAlD
Caffeine—Infection—Etoposide—sarcoma	0.000245	0.00478	CcSEcCtD
Caffeine—Blood creatinine increased—Doxorubicin—sarcoma	0.000244	0.00475	CcSEcCtD
Caffeine—CYP2D6—hematopoietic system—sarcoma	0.000241	0.00184	CbGeAlD
Caffeine—Tachycardia—Etoposide—sarcoma	0.00024	0.00469	CcSEcCtD
Caffeine—Skin disorder—Etoposide—sarcoma	0.000239	0.00467	CcSEcCtD
Caffeine—Dry skin—Doxorubicin—sarcoma	0.000238	0.00465	CcSEcCtD
Caffeine—Gastritis—Doxorubicin—sarcoma	0.00023	0.00449	CcSEcCtD
Caffeine—Hypersensitivity—Vincristine—sarcoma	0.000224	0.00437	CcSEcCtD
Caffeine—Dyspnoea—Etoposide—sarcoma	0.00022	0.00429	CcSEcCtD
Caffeine—PDE4B—lymph node—sarcoma	0.000219	0.00167	CbGeAlD
Caffeine—Hyperglycaemia—Epirubicin—sarcoma	0.000219	0.00428	CcSEcCtD
Caffeine—Hypersensitivity—Mitoxantrone—sarcoma	0.000218	0.00426	CcSEcCtD
Caffeine—Infestation—Epirubicin—sarcoma	0.000217	0.00423	CcSEcCtD
Caffeine—Infestation NOS—Epirubicin—sarcoma	0.000217	0.00423	CcSEcCtD
Caffeine—Rash—Thiotepa—sarcoma	0.000216	0.00422	CcSEcCtD
Caffeine—Dermatitis—Thiotepa—sarcoma	0.000216	0.00422	CcSEcCtD
Caffeine—Rash—Dactinomycin—sarcoma	0.000215	0.00419	CcSEcCtD
Caffeine—CYP2E1—lymphoid tissue—sarcoma	0.000215	0.00164	CbGeAlD
Caffeine—Renal failure—Epirubicin—sarcoma	0.000213	0.00415	CcSEcCtD
Caffeine—Gastrointestinal disorder—Etoposide—sarcoma	0.000213	0.00415	CcSEcCtD
Caffeine—Hyperglycaemia—Doxorubicin—sarcoma	0.000203	0.00396	CcSEcCtD
Caffeine—ABCB1—myometrium—sarcoma	0.000202	0.00154	CbGeAlD
Caffeine—CYP2E1—tendon—sarcoma	0.000202	0.00154	CbGeAlD
Caffeine—Infestation—Doxorubicin—sarcoma	0.0002	0.00391	CcSEcCtD
Caffeine—Infestation NOS—Doxorubicin—sarcoma	0.0002	0.00391	CcSEcCtD
Caffeine—CYP2C8—testis—sarcoma	0.000198	0.00151	CbGeAlD
Caffeine—Renal failure—Doxorubicin—sarcoma	0.000197	0.00384	CcSEcCtD
Caffeine—Haemoglobin—Epirubicin—sarcoma	0.000195	0.00381	CcSEcCtD
Caffeine—ABCB1—embryo—sarcoma	0.000195	0.00148	CbGeAlD
Caffeine—Haemorrhage—Epirubicin—sarcoma	0.000194	0.00379	CcSEcCtD
Caffeine—Rash—Vincristine—sarcoma	0.000192	0.00374	CcSEcCtD
Caffeine—Dermatitis—Vincristine—sarcoma	0.000192	0.00374	CcSEcCtD
Caffeine—CYP1B1—lymph node—sarcoma	0.000188	0.00143	CbGeAlD
Caffeine—CYP2C8—liver—sarcoma	0.000188	0.00143	CbGeAlD
Caffeine—Rash—Mitoxantrone—sarcoma	0.000187	0.00364	CcSEcCtD
Caffeine—Dermatitis—Mitoxantrone—sarcoma	0.000187	0.00364	CcSEcCtD
Caffeine—ABCB1—seminal vesicle—sarcoma	0.000183	0.00139	CbGeAlD
Caffeine—Hypersensitivity—Etoposide—sarcoma	0.000182	0.00354	CcSEcCtD
Caffeine—Haemoglobin—Doxorubicin—sarcoma	0.000181	0.00353	CcSEcCtD
Caffeine—Cardiac disorder—Epirubicin—sarcoma	0.00018	0.00352	CcSEcCtD
Caffeine—Haemorrhage—Doxorubicin—sarcoma	0.00018	0.00351	CcSEcCtD
Caffeine—Immune system disorder—Epirubicin—sarcoma	0.000176	0.00343	CcSEcCtD
Caffeine—CYP1A2—liver—sarcoma	0.000176	0.00134	CbGeAlD
Caffeine—ABCB1—hematopoietic system—sarcoma	0.000174	0.00133	CbGeAlD
Caffeine—CYP1A1—liver—sarcoma	0.000173	0.00132	CbGeAlD
Caffeine—CYP3A5—liver—sarcoma	0.000169	0.00129	CbGeAlD
Caffeine—Malnutrition—Epirubicin—sarcoma	0.000169	0.0033	CcSEcCtD
Caffeine—CYP2E1—testis—sarcoma	0.000167	0.00127	CbGeAlD
Caffeine—Cardiac disorder—Doxorubicin—sarcoma	0.000167	0.00326	CcSEcCtD
Caffeine—CYP2C9—liver—sarcoma	0.000167	0.00127	CbGeAlD
Caffeine—Nervousness—Epirubicin—sarcoma	0.000164	0.00321	CcSEcCtD
Caffeine—Immune system disorder—Doxorubicin—sarcoma	0.000162	0.00317	CcSEcCtD
Caffeine—CYP2E1—liver—sarcoma	0.000158	0.00121	CbGeAlD
Caffeine—Malnutrition—Doxorubicin—sarcoma	0.000157	0.00306	CcSEcCtD
Caffeine—Agitation—Epirubicin—sarcoma	0.000156	0.00304	CcSEcCtD
Caffeine—Rash—Etoposide—sarcoma	0.000155	0.00303	CcSEcCtD
Caffeine—Dermatitis—Etoposide—sarcoma	0.000155	0.00303	CcSEcCtD
Caffeine—Nervousness—Doxorubicin—sarcoma	0.000152	0.00297	CcSEcCtD
Caffeine—Convulsion—Epirubicin—sarcoma	0.000147	0.00286	CcSEcCtD
Caffeine—Hypertension—Epirubicin—sarcoma	0.000146	0.00285	CcSEcCtD
Caffeine—Agitation—Doxorubicin—sarcoma	0.000144	0.00281	CcSEcCtD
Caffeine—Infection—Epirubicin—sarcoma	0.000137	0.00268	CcSEcCtD
Caffeine—Convulsion—Doxorubicin—sarcoma	0.000136	0.00265	CcSEcCtD
Caffeine—Nervous system disorder—Epirubicin—sarcoma	0.000135	0.00264	CcSEcCtD
Caffeine—Hypertension—Doxorubicin—sarcoma	0.000135	0.00264	CcSEcCtD
Caffeine—Tachycardia—Epirubicin—sarcoma	0.000135	0.00263	CcSEcCtD
Caffeine—Skin disorder—Epirubicin—sarcoma	0.000134	0.00262	CcSEcCtD
Caffeine—CYP1A1—lymph node—sarcoma	0.000133	0.00101	CbGeAlD
Caffeine—CYP2D6—testis—sarcoma	0.000132	0.00101	CbGeAlD
Caffeine—ABCB1—uterus—sarcoma	0.000131	0.001	CbGeAlD
Caffeine—CYP3A4—liver—sarcoma	0.000127	0.00097	CbGeAlD
Caffeine—Infection—Doxorubicin—sarcoma	0.000127	0.00248	CcSEcCtD
Caffeine—Nervous system disorder—Doxorubicin—sarcoma	0.000125	0.00245	CcSEcCtD
Caffeine—CYP2D6—liver—sarcoma	0.000125	0.000954	CbGeAlD
Caffeine—Tachycardia—Doxorubicin—sarcoma	0.000125	0.00243	CcSEcCtD
Caffeine—Skin disorder—Doxorubicin—sarcoma	0.000124	0.00242	CcSEcCtD
Caffeine—Dyspnoea—Epirubicin—sarcoma	0.000123	0.0024	CcSEcCtD
Caffeine—ABCB1—lymphoid tissue—sarcoma	0.000122	0.000933	CbGeAlD
Caffeine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000119	0.00233	CcSEcCtD
Caffeine—Dyspnoea—Doxorubicin—sarcoma	0.000114	0.00222	CcSEcCtD
Caffeine—ABCB1—bone marrow—sarcoma	0.000111	0.000849	CbGeAlD
Caffeine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00011	0.00215	CcSEcCtD
Caffeine—Hypersensitivity—Epirubicin—sarcoma	0.000102	0.00199	CcSEcCtD
Caffeine—ABCB1—testis—sarcoma	9.52e-05	0.000726	CbGeAlD
Caffeine—Hypersensitivity—Doxorubicin—sarcoma	9.42e-05	0.00184	CcSEcCtD
Caffeine—ABCB1—liver—sarcoma	9e-05	0.000687	CbGeAlD
Caffeine—Rash—Epirubicin—sarcoma	8.71e-05	0.0017	CcSEcCtD
Caffeine—Dermatitis—Epirubicin—sarcoma	8.7e-05	0.0017	CcSEcCtD
Caffeine—Rash—Doxorubicin—sarcoma	8.06e-05	0.00157	CcSEcCtD
Caffeine—Dermatitis—Doxorubicin—sarcoma	8.05e-05	0.00157	CcSEcCtD
Caffeine—ABCB1—lymph node—sarcoma	6.9e-05	0.000526	CbGeAlD
Caffeine—ADORA1—Signaling Pathways—PDGFRB—sarcoma	1.53e-05	6.15e-05	CbGpPWpGaD
Caffeine—PIK3CB—Adaptive Immune System—HRAS—sarcoma	1.52e-05	6.14e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—FOXO1—sarcoma	1.51e-05	6.09e-05	CbGpPWpGaD
Caffeine—PDE4B—GPCR downstream signaling—IL2—sarcoma	1.51e-05	6.09e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—CREB1—sarcoma	1.51e-05	6.09e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—PDGFRB—sarcoma	1.51e-05	6.08e-05	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—SRC—sarcoma	1.51e-05	6.08e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—IL2—sarcoma	1.51e-05	6.07e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—IGF1R—sarcoma	1.5e-05	6.06e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—PDGFRA—sarcoma	1.5e-05	6.06e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—KDR—sarcoma	1.5e-05	6.05e-05	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—EGFR—sarcoma	1.5e-05	6.03e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—ENO2—sarcoma	1.49e-05	6.03e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—KDR—sarcoma	1.49e-05	6e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—HBA1—sarcoma	1.49e-05	5.99e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—PDGFRA—sarcoma	1.48e-05	5.99e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—CREB1—sarcoma	1.48e-05	5.97e-05	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—KRAS—sarcoma	1.47e-05	5.93e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—JUN—sarcoma	1.46e-05	5.9e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—CTNNB1—sarcoma	1.45e-05	5.86e-05	CbGpPWpGaD
Caffeine—PIK3CA—Hemostasis—TP53—sarcoma	1.45e-05	5.86e-05	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—NRAS—sarcoma	1.45e-05	5.84e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—CREB1—sarcoma	1.45e-05	5.84e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—EGFR—sarcoma	1.45e-05	5.83e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—FOXO1—sarcoma	1.43e-05	5.77e-05	CbGpPWpGaD
Caffeine—PIK3CA—GPCR downstream signaling—IL2—sarcoma	1.43e-05	5.76e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—PDGFRB—sarcoma	1.43e-05	5.76e-05	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—KRAS—sarcoma	1.41e-05	5.7e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PLCG1—sarcoma	1.41e-05	5.67e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—PDGFRA—sarcoma	1.41e-05	5.67e-05	CbGpPWpGaD
Caffeine—PIK3CD—Disease—SRC—sarcoma	1.39e-05	5.61e-05	CbGpPWpGaD
Caffeine—PIK3CA—Hemostasis—HRAS—sarcoma	1.39e-05	5.6e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—IL2—sarcoma	1.39e-05	5.6e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—KIT—sarcoma	1.38e-05	5.58e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—NRAS—sarcoma	1.38e-05	5.58e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	1.38e-05	5.56e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	1.38e-05	5.55e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—IL2—sarcoma	1.37e-05	5.53e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—KIT—sarcoma	1.37e-05	5.52e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—NRAS—sarcoma	1.37e-05	5.52e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	1.37e-05	5.51e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—KRAS—sarcoma	1.37e-05	5.51e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—CTNNB1—sarcoma	1.34e-05	5.41e-05	CbGpPWpGaD
Caffeine—PIK3CD—Disease—NRAS—sarcoma	1.34e-05	5.4e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—MDM2—sarcoma	1.33e-05	5.35e-05	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—EGFR—sarcoma	1.32e-05	5.32e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—CREB1—sarcoma	1.32e-05	5.31e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—SRC—sarcoma	1.31e-05	5.3e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—CREB1—sarcoma	1.3e-05	5.26e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—IL2—sarcoma	1.3e-05	5.23e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PLCG1—sarcoma	1.27e-05	5.11e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—KDR—sarcoma	1.26e-05	5.1e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—NRAS—sarcoma	1.26e-05	5.09e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—EGFR—sarcoma	1.26e-05	5.08e-05	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—HRAS—sarcoma	1.25e-05	5.04e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—KDR—sarcoma	1.25e-05	5.04e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—MDM2—sarcoma	1.25e-05	5.04e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—EGFR—sarcoma	1.25e-05	5.03e-05	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—KRAS—sarcoma	1.25e-05	5.03e-05	CbGpPWpGaD
Caffeine—PIK3CD—Disease—MYC—sarcoma	1.25e-05	5.03e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—IGF1R—sarcoma	1.24e-05	5e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	1.23e-05	4.98e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—MDM2—sarcoma	1.23e-05	4.94e-05	CbGpPWpGaD
Caffeine—PIK3CD—Disease—EGFR—sarcoma	1.22e-05	4.92e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—SRC—sarcoma	1.21e-05	4.89e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	1.2e-05	4.85e-05	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—HRAS—sarcoma	1.2e-05	4.84e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—KRAS—sarcoma	1.19e-05	4.8e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—IL2—sarcoma	1.19e-05	4.78e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—KDR—sarcoma	1.18e-05	4.77e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—FOXO1—sarcoma	1.18e-05	4.76e-05	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—IL2—sarcoma	1.18e-05	4.76e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—KRAS—sarcoma	1.18e-05	4.75e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—PDGFRB—sarcoma	1.18e-05	4.75e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—NRAS—sarcoma	1.17e-05	4.7e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—KIT—sarcoma	1.17e-05	4.7e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—NRAS—sarcoma	1.17e-05	4.7e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—HRAS—sarcoma	1.16e-05	4.68e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—PDGFRA—sarcoma	1.16e-05	4.68e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—JUN—sarcoma	1.15e-05	4.65e-05	CbGpPWpGaD
Caffeine—PIK3CD—Disease—KRAS—sarcoma	1.15e-05	4.64e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—KIT—sarcoma	1.15e-05	4.64e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—NRAS—sarcoma	1.15e-05	4.64e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—EGFR—sarcoma	1.15e-05	4.64e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—CTNNB1—sarcoma	1.15e-05	4.62e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—IL2—sarcoma	1.12e-05	4.5e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CREB1—sarcoma	1.11e-05	4.47e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	1.11e-05	4.46e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CREB1—sarcoma	1.1e-05	4.42e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—KIT—sarcoma	1.09e-05	4.39e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—NRAS—sarcoma	1.09e-05	4.39e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—MDM2—sarcoma	1.09e-05	4.39e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—CCND1—sarcoma	1.09e-05	4.39e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—KRAS—sarcoma	1.09e-05	4.38e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—MYC—sarcoma	1.09e-05	4.38e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—JUN—sarcoma	1.09e-05	4.38e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—ENO2—sarcoma	1.08e-05	4.37e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	1.08e-05	4.36e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—ENO2—sarcoma	1.08e-05	4.36e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—MDM2—sarcoma	1.08e-05	4.35e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—CTNNB1—sarcoma	1.08e-05	4.35e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—HBA1—sarcoma	1.08e-05	4.34e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—HBA1—sarcoma	1.07e-05	4.33e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—IL2—sarcoma	1.07e-05	4.32e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—EGFR—sarcoma	1.06e-05	4.29e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—EGFR—sarcoma	1.06e-05	4.28e-05	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—HRAS—sarcoma	1.06e-05	4.28e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—CTNNB1—sarcoma	1.06e-05	4.26e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—EGFR—sarcoma	1.05e-05	4.23e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CREB1—sarcoma	1.04e-05	4.18e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—SRC—sarcoma	1.04e-05	4.17e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	1.02e-05	4.12e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—ENO2—sarcoma	1.02e-05	4.12e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—HBA1—sarcoma	1.01e-05	4.09e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—HRAS—sarcoma	1.01e-05	4.08e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—KRAS—sarcoma	1e-05	4.05e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—KRAS—sarcoma	1e-05	4.04e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—HRAS—sarcoma	1e-05	4.04e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—NRAS—sarcoma	9.96e-06	4.01e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—EGFR—sarcoma	9.93e-06	4e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—KRAS—sarcoma	9.91e-06	3.99e-05	CbGpPWpGaD
Caffeine—PIK3CD—Disease—HRAS—sarcoma	9.79e-06	3.95e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—KDR—sarcoma	9.77e-06	3.94e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—SRC—sarcoma	9.74e-06	3.93e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—IL2—sarcoma	9.73e-06	3.92e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—IL2—sarcoma	9.64e-06	3.89e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—SRC—sarcoma	9.56e-06	3.85e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—VEGFA—sarcoma	9.49e-06	3.83e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—CCND1—sarcoma	9.49e-06	3.82e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—JUN—sarcoma	9.47e-06	3.82e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—CCND1—sarcoma	9.4e-06	3.79e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—CTNNB1—sarcoma	9.39e-06	3.79e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—JUN—sarcoma	9.38e-06	3.78e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—KRAS—sarcoma	9.38e-06	3.78e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—NRAS—sarcoma	9.37e-06	3.78e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—ENO2—sarcoma	9.36e-06	3.77e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—CTNNB1—sarcoma	9.31e-06	3.75e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—HBA1—sarcoma	9.3e-06	3.75e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—HRAS—sarcoma	9.24e-06	3.73e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—NRAS—sarcoma	9.19e-06	3.71e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PLCG1—sarcoma	9.19e-06	3.7e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—MDM2—sarcoma	9.18e-06	3.7e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PLCG1—sarcoma	9.17e-06	3.7e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	9.09e-06	3.66e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—EGFR—sarcoma	9.07e-06	3.66e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—MDM2—sarcoma	9.07e-06	3.66e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—KIT—sarcoma	9e-06	3.63e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—NRAS—sarcoma	9e-06	3.63e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—MYC—sarcoma	8.73e-06	3.52e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PLCG1—sarcoma	8.66e-06	3.49e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—MDM2—sarcoma	8.58e-06	3.46e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—KRAS—sarcoma	8.57e-06	3.46e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—MYC—sarcoma	8.56e-06	3.45e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CREB1—sarcoma	8.56e-06	3.45e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—EGFR—sarcoma	8.54e-06	3.44e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—HRAS—sarcoma	8.53e-06	3.44e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—HRAS—sarcoma	8.52e-06	3.44e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—SRC—sarcoma	8.49e-06	3.42e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—HRAS—sarcoma	8.42e-06	3.4e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—SRC—sarcoma	8.41e-06	3.39e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—EGFR—sarcoma	8.38e-06	3.38e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—VEGFA—sarcoma	8.27e-06	3.33e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—IL2—sarcoma	8.2e-06	3.31e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—EGFR—sarcoma	8.2e-06	3.3e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—VEGFA—sarcoma	8.19e-06	3.3e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—NRAS—sarcoma	8.17e-06	3.29e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—ENO2—sarcoma	8.15e-06	3.29e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—HBA1—sarcoma	8.1e-06	3.27e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—IL2—sarcoma	8.1e-06	3.27e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—NRAS—sarcoma	8.09e-06	3.26e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—KRAS—sarcoma	8.07e-06	3.25e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CCND1—sarcoma	7.99e-06	3.22e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—JUN—sarcoma	7.98e-06	3.22e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—HRAS—sarcoma	7.97e-06	3.21e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PLCG1—sarcoma	7.94e-06	3.2e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CTNNB1—sarcoma	7.91e-06	3.19e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—KRAS—sarcoma	7.91e-06	3.19e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CCND1—sarcoma	7.9e-06	3.18e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—JUN—sarcoma	7.88e-06	3.18e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CTNNB1—sarcoma	7.82e-06	3.15e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—KRAS—sarcoma	7.74e-06	3.12e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ENO2—sarcoma	7.68e-06	3.1e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—IL2—sarcoma	7.67e-06	3.09e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—HBA1—sarcoma	7.63e-06	3.08e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ENO2—sarcoma	7.62e-06	3.07e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—MYC—sarcoma	7.61e-06	3.07e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—HBA1—sarcoma	7.57e-06	3.05e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—MYC—sarcoma	7.54e-06	3.04e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CCND1—sarcoma	7.48e-06	3.01e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—JUN—sarcoma	7.46e-06	3.01e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—EGFR—sarcoma	7.44e-06	3e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CTNNB1—sarcoma	7.4e-06	2.98e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—EGFR—sarcoma	7.37e-06	2.97e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—HRAS—sarcoma	7.28e-06	2.94e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—TP53—sarcoma	7.17e-06	2.89e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—SRC—sarcoma	7.15e-06	2.88e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MDM2—sarcoma	7.08e-06	2.86e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—SRC—sarcoma	7.07e-06	2.85e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—KRAS—sarcoma	7.03e-06	2.83e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—VEGFA—sarcoma	6.97e-06	2.81e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—KRAS—sarcoma	6.97e-06	2.81e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PLCG1—sarcoma	6.92e-06	2.79e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—VEGFA—sarcoma	6.89e-06	2.78e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—NRAS—sarcoma	6.88e-06	2.77e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—HRAS—sarcoma	6.86e-06	2.76e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—NRAS—sarcoma	6.8e-06	2.74e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—HRAS—sarcoma	6.73e-06	2.71e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—SRC—sarcoma	6.69e-06	2.7e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—HRAS—sarcoma	6.58e-06	2.65e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PLCG1—sarcoma	6.52e-06	2.63e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—VEGFA—sarcoma	6.52e-06	2.63e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ENO2—sarcoma	6.51e-06	2.62e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—HBA1—sarcoma	6.47e-06	2.61e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PLCG1—sarcoma	6.46e-06	2.61e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—NRAS—sarcoma	6.44e-06	2.6e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—MYC—sarcoma	6.41e-06	2.58e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—MYC—sarcoma	6.33e-06	2.55e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—IL2—sarcoma	6.33e-06	2.55e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—EGFR—sarcoma	6.27e-06	2.53e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—TP53—sarcoma	6.25e-06	2.52e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—EGFR—sarcoma	6.2e-06	2.5e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—TP53—sarcoma	6.19e-06	2.5e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CCND1—sarcoma	6.17e-06	2.49e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—JUN—sarcoma	6.16e-06	2.48e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CTNNB1—sarcoma	6.11e-06	2.46e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—MYC—sarcoma	6e-06	2.42e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—HRAS—sarcoma	5.98e-06	2.41e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—KRAS—sarcoma	5.92e-06	2.39e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—HRAS—sarcoma	5.92e-06	2.39e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—EGFR—sarcoma	5.87e-06	2.36e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—KRAS—sarcoma	5.85e-06	2.36e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—KRAS—sarcoma	5.54e-06	2.23e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—SRC—sarcoma	5.52e-06	2.23e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PLCG1—sarcoma	5.52e-06	2.23e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—VEGFA—sarcoma	5.38e-06	2.17e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—NRAS—sarcoma	5.31e-06	2.14e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—TP53—sarcoma	5.26e-06	2.12e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—TP53—sarcoma	5.2e-06	2.1e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—HRAS—sarcoma	5.04e-06	2.03e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ENO2—sarcoma	5.02e-06	2.03e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—HBA1—sarcoma	4.99e-06	2.01e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—HRAS—sarcoma	4.98e-06	2.01e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MYC—sarcoma	4.95e-06	2e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—TP53—sarcoma	4.92e-06	1.99e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—EGFR—sarcoma	4.84e-06	1.95e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—HRAS—sarcoma	4.71e-06	1.9e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—KRAS—sarcoma	4.57e-06	1.84e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PLCG1—sarcoma	4.26e-06	1.72e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TP53—sarcoma	4.06e-06	1.64e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—HRAS—sarcoma	3.89e-06	1.57e-05	CbGpPWpGaD
